Jakarta - PT Itama Ranoraya Tbk (IRRA) again received a contract for 88 million Auto Disable Syringe (ADS) syringes of 88.7 million units.

With this acquisition, the company has booked a contract to supply syringes for the government's vaccination program, a total of 141 million ADS (Auto Disable Syringe) syringes.

The syringe sales consisted of ADS 52.5 million for the 0.3 ml size acquired in October and 88.7 million ADS for the 0.5 ml size obtained today. The acquisition of the 141 million ADS syringe contract made the company's sales of ADS syringes reach 169 million until early December 2021.

President Director of Itama Heru Firdausi Syarif revealed that the need for syringes for the Covid vaccination program in Indonesia this year has been fulfilled, and the availability of needles for vaccination needs next year.

The completion of a new factory owned by PT Oneject Indonesia (Oneject) with an additional capacity of 1.2 billion ADS